Using PICO Methodology to Answer Questions About Smoking in COPD Patients

The ALAT and SEPAR Treatment and Control of Smoking Groups have collaborated in the preparation of this document which attempts to answer, by way of PICO methodology, different questions on health interventions for helping COPD patients to stop smoking. The main recommendations are: (i) moderate-qua...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2017
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/22844
Acceso en línea:
https://doi.org/10.1016/j.arbres.2017.04.012
https://repository.urosario.edu.co/handle/10336/22844
Palabra clave:
Article
Chronic obstructive lung disease
Counseling
High risk patient
Hospital discharge
Hospitalization
Human
Smoking
Smoking cessation
Spirometry
Age
Health economics
High risk population
Smoking habit
Chronic obstructive lung disease
Clinical trial (topic)
Cost benefit analysis
Drug therapy
Economics
Evidence based medicine
Motivation
Pathophysiology
Procedures
Psychology
Questionnaire
Randomized controlled trial (topic)
Smoking
Therapy
Amfebutamone
Biological marker
Nicotine
Nicotinic agent
Varenicline
Biomarkers
Bupropion
Clinical Trials as Topic
Cost-Benefit Analysis
Counseling
Evidence-Based Medicine
Humans
Motivation
Nicotine
Nicotinic Agonists
Randomized Controlled Trials as Topic
Smoking
Smoking Cessation
Spirometry
Surveys and Questionnaires
Varenicline
Chronic obstructive pulmonary disease
Smoking
Spirometry
Treatment
Chronic Obstructive
Pulmonary Disease
Rights
License
Abierto (Texto Completo)
id EDOCUR2_b08d3267bb43801e02d637e08c4030d2
oai_identifier_str oai:repository.urosario.edu.co:10336/22844
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
spelling bf2e764c-74a1-4eab-8320-5fefc2f5870d-11dcf4a75-7f4c-4f79-b80d-c94d7e003b20-12165c876-9d73-4a82-b63e-8d1b985152cf-1d334f774-9fe5-4230-9af9-3ff7f58b2193-198182fc3-ff8b-46be-bb79-4ae142fc6e78-1be3b31e1-eedd-4eb9-86e3-6d2997f9ddce-149e92ebc-d75c-41cc-b642-f08bb284b7b7-1c76f13e5-0cf9-48e1-89e2-96e31a259cbb-1fb43f270-0c43-48e9-b302-b7fe14d7f7e5-122c4c36f-b086-4de1-be37-32625e55e270-134318d1b-d3e2-4948-ade5-df096c2e9f5d-152f38d2c-99b8-4056-923d-ebfb5ea4a87c-186cf804c-49ed-4551-b199-89afa88460ff-1896214f8-a539-44cd-b31f-e9fffc2697d9-1f057f8a7-f594-4591-b88b-286c7ce5322a-13251e019-5c56-401b-abde-48469007729f-12020-05-25T23:58:21Z2020-05-25T23:58:21Z2017The ALAT and SEPAR Treatment and Control of Smoking Groups have collaborated in the preparation of this document which attempts to answer, by way of PICO methodology, different questions on health interventions for helping COPD patients to stop smoking. The main recommendations are: (i) moderate-quality evidence and strong recommendation for performing spirometry in COPD patients and in smokers with a high risk of developing the disease, as a motivational tool (particularly for showing evidence of lung age), a diagnostic tool, and for active case-finding; (ii) high-quality evidence and strong recommendation for using intensive dedicated behavioral counselling and drug treatment for helping COPD patients to stop smoking; (iii) high-quality evidence and strong recommendation for initiating interventions for helping COPD patients to stop smoking during hospitalization with improvement when the intervention is prolonged after discharge, and (iv) high-quality evidence and strong recommendation for funding treatment of smoking in COPD patients, in view of the impact on health and health economics. © 2017 SEPARapplication/pdfhttps://doi.org/10.1016/j.arbres.2017.04.0123002896https://repository.urosario.edu.co/handle/10336/22844engElsevier Doyma628No. 11622Archivos de BronconeumologiaVol. 53Archivos de Bronconeumologia, ISSN:3002896, Vol.53, No.11 (2017); pp. 622-628https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044788291&doi=10.1016%2fj.arbres.2017.04.012&partnerID=40&md5=1a73c119424c3fc87652814daeea1b5eAbierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURArticleChronic obstructive lung diseaseCounselingHigh risk patientHospital dischargeHospitalizationHumanSmokingSmoking cessationSpirometryAgeHealth economicsHigh risk populationSmoking habitChronic obstructive lung diseaseClinical trial (topic)Cost benefit analysisDrug therapyEconomicsEvidence based medicineMotivationPathophysiologyProceduresPsychologyQuestionnaireRandomized controlled trial (topic)SmokingTherapyAmfebutamoneBiological markerNicotineNicotinic agentVareniclineBiomarkersBupropionClinical Trials as TopicCost-Benefit AnalysisCounselingEvidence-Based MedicineHumansMotivationNicotineNicotinic AgonistsRandomized Controlled Trials as TopicSmokingSmoking CessationSpirometrySurveys and QuestionnairesVareniclineChronic obstructive pulmonary diseaseSmokingSpirometryTreatmentChronic ObstructivePulmonary DiseaseUsing PICO Methodology to Answer Questions About Smoking in COPD PatientsPreguntas y respuestas relacionadas con tabaquismo en pacientes con EPOC. Aplicación de metodología con formato PICOarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Jiménez Ruiz C.A.Buljubasich D.Riesco Miranda J.A.Acuña Izcaray A.de Granda Orive J.I.Chatkin J.M.Zabert G.Guerreros Benavides A.Paez Espinel N.Noé V.Sánchez-Angarita E.Núñez-Sánchez I.Sansores R.H.Casas A.Palomar Lever A.Alfageme Michavila I.10336/22844oai:repository.urosario.edu.co:10336/228442022-05-02 07:37:20.799559https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co
dc.title.spa.fl_str_mv Using PICO Methodology to Answer Questions About Smoking in COPD Patients
dc.title.TranslatedTitle.spa.fl_str_mv Preguntas y respuestas relacionadas con tabaquismo en pacientes con EPOC. Aplicación de metodología con formato PICO
title Using PICO Methodology to Answer Questions About Smoking in COPD Patients
spellingShingle Using PICO Methodology to Answer Questions About Smoking in COPD Patients
Article
Chronic obstructive lung disease
Counseling
High risk patient
Hospital discharge
Hospitalization
Human
Smoking
Smoking cessation
Spirometry
Age
Health economics
High risk population
Smoking habit
Chronic obstructive lung disease
Clinical trial (topic)
Cost benefit analysis
Drug therapy
Economics
Evidence based medicine
Motivation
Pathophysiology
Procedures
Psychology
Questionnaire
Randomized controlled trial (topic)
Smoking
Therapy
Amfebutamone
Biological marker
Nicotine
Nicotinic agent
Varenicline
Biomarkers
Bupropion
Clinical Trials as Topic
Cost-Benefit Analysis
Counseling
Evidence-Based Medicine
Humans
Motivation
Nicotine
Nicotinic Agonists
Randomized Controlled Trials as Topic
Smoking
Smoking Cessation
Spirometry
Surveys and Questionnaires
Varenicline
Chronic obstructive pulmonary disease
Smoking
Spirometry
Treatment
Chronic Obstructive
Pulmonary Disease
title_short Using PICO Methodology to Answer Questions About Smoking in COPD Patients
title_full Using PICO Methodology to Answer Questions About Smoking in COPD Patients
title_fullStr Using PICO Methodology to Answer Questions About Smoking in COPD Patients
title_full_unstemmed Using PICO Methodology to Answer Questions About Smoking in COPD Patients
title_sort Using PICO Methodology to Answer Questions About Smoking in COPD Patients
dc.subject.keyword.spa.fl_str_mv Article
Chronic obstructive lung disease
Counseling
High risk patient
Hospital discharge
Hospitalization
Human
Smoking
Smoking cessation
Spirometry
Age
Health economics
High risk population
Smoking habit
Chronic obstructive lung disease
Clinical trial (topic)
Cost benefit analysis
Drug therapy
Economics
Evidence based medicine
Motivation
Pathophysiology
Procedures
Psychology
Questionnaire
Randomized controlled trial (topic)
Smoking
Therapy
Amfebutamone
Biological marker
Nicotine
Nicotinic agent
Varenicline
Biomarkers
Bupropion
Clinical Trials as Topic
Cost-Benefit Analysis
Counseling
Evidence-Based Medicine
Humans
Motivation
Nicotine
Nicotinic Agonists
Randomized Controlled Trials as Topic
Smoking
Smoking Cessation
Spirometry
Surveys and Questionnaires
Varenicline
Chronic obstructive pulmonary disease
Smoking
Spirometry
Treatment
topic Article
Chronic obstructive lung disease
Counseling
High risk patient
Hospital discharge
Hospitalization
Human
Smoking
Smoking cessation
Spirometry
Age
Health economics
High risk population
Smoking habit
Chronic obstructive lung disease
Clinical trial (topic)
Cost benefit analysis
Drug therapy
Economics
Evidence based medicine
Motivation
Pathophysiology
Procedures
Psychology
Questionnaire
Randomized controlled trial (topic)
Smoking
Therapy
Amfebutamone
Biological marker
Nicotine
Nicotinic agent
Varenicline
Biomarkers
Bupropion
Clinical Trials as Topic
Cost-Benefit Analysis
Counseling
Evidence-Based Medicine
Humans
Motivation
Nicotine
Nicotinic Agonists
Randomized Controlled Trials as Topic
Smoking
Smoking Cessation
Spirometry
Surveys and Questionnaires
Varenicline
Chronic obstructive pulmonary disease
Smoking
Spirometry
Treatment
Chronic Obstructive
Pulmonary Disease
dc.subject.keyword.eng.fl_str_mv Chronic Obstructive
Pulmonary Disease
description The ALAT and SEPAR Treatment and Control of Smoking Groups have collaborated in the preparation of this document which attempts to answer, by way of PICO methodology, different questions on health interventions for helping COPD patients to stop smoking. The main recommendations are: (i) moderate-quality evidence and strong recommendation for performing spirometry in COPD patients and in smokers with a high risk of developing the disease, as a motivational tool (particularly for showing evidence of lung age), a diagnostic tool, and for active case-finding; (ii) high-quality evidence and strong recommendation for using intensive dedicated behavioral counselling and drug treatment for helping COPD patients to stop smoking; (iii) high-quality evidence and strong recommendation for initiating interventions for helping COPD patients to stop smoking during hospitalization with improvement when the intervention is prolonged after discharge, and (iv) high-quality evidence and strong recommendation for funding treatment of smoking in COPD patients, in view of the impact on health and health economics. © 2017 SEPAR
publishDate 2017
dc.date.created.spa.fl_str_mv 2017
dc.date.accessioned.none.fl_str_mv 2020-05-25T23:58:21Z
dc.date.available.none.fl_str_mv 2020-05-25T23:58:21Z
dc.type.eng.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv Artículo
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1016/j.arbres.2017.04.012
dc.identifier.issn.none.fl_str_mv 3002896
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/22844
url https://doi.org/10.1016/j.arbres.2017.04.012
https://repository.urosario.edu.co/handle/10336/22844
identifier_str_mv 3002896
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.citationEndPage.none.fl_str_mv 628
dc.relation.citationIssue.none.fl_str_mv No. 11
dc.relation.citationStartPage.none.fl_str_mv 622
dc.relation.citationTitle.none.fl_str_mv Archivos de Bronconeumologia
dc.relation.citationVolume.none.fl_str_mv Vol. 53
dc.relation.ispartof.spa.fl_str_mv Archivos de Bronconeumologia, ISSN:3002896, Vol.53, No.11 (2017); pp. 622-628
dc.relation.uri.spa.fl_str_mv https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044788291&doi=10.1016%2fj.arbres.2017.04.012&partnerID=40&md5=1a73c119424c3fc87652814daeea1b5e
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.acceso.spa.fl_str_mv Abierto (Texto Completo)
rights_invalid_str_mv Abierto (Texto Completo)
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Elsevier Doyma
institution Universidad del Rosario
dc.source.instname.spa.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.spa.fl_str_mv reponame:Repositorio Institucional EdocUR
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1814167644202336256